Cargando…
Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model
Metastatic castration resistant prostate cancer (mCRPC) is commonly treated by androgen deprivation therapy (ADT) in combination with chemotherapy. Immune therapy by checkpoint inhibitors, has become a powerful new tool in the treatment of melanoma and lung cancer, and it is currently being used in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752026/ https://www.ncbi.nlm.nih.gov/pubmed/35015785 http://dx.doi.org/10.1371/journal.pone.0262453 |